2015 Congress of Neurological Surgeons Annual Meeting Objectives
The Congress of Neurological Surgeons exists to enhance health and improve lives worldwide through the advancement of education and scientific exchange. The CNS Continuing Medical Education (CME) program provides participants with various learning formats to keep current in the field and to improve skills and enhance professional performance to provide the best possible care for their patients.
The CNS CME program is designed, planned, and implemented to evaluate a comprehensive collection of activities within the subspecialty of neurosurgery. The CNS plans to yield results that not only contribute to lifelong learning, but also demonstrate change and improvement in competence.
At the conclusion of the 2015 CNS Annual Meeting participants will be able to:
- Alter their current practice patterns in accordance with the latest data.
- Compare techniques based on findings discussed during case presentations.
- Apply and/or perform new techniques based on best practices and current procedures.
- Practice evidence-based, informed neurosurgical medicine.
- Interpret newly found outcomes as a result of the scientific abstract presentations.
- Demonstrate change in competence.
The Congress of Neurological Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The CNS designates this live activity for a maximum of 47.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*A maximum of 22.75 AMA PRA Category 1 CreditsTM may be earned for general sessions only.
Please note: CME credit is not available for SYM02: Neurovation, PC15: Simulation-Based Neurosurgical Training and the Live Surgeries in the Exhibit Hall.
CME credit earned at the CNS Annual Meeting can be applied towards Part II of Maintenance of Certification.
Physicians may claim a maximum of five (5) AMA PRA Category 1 CreditsTM directly from the AMA for preparing a poster presentation, which is also included in the published abstracts.
Physicians may claim them on their AMA PRA certificate application or apply directly to the AMA for an AMA PRA Category 1 CreditsTM certificate.
Physicians may claim AMA PRA Category 2 CreditsTM for viewing scientific posters. Physicians should self-claim credit on their AMA PRA certificate application form. Please visit the AMA web site for details at www.ama-assn.org.
Advanced Practice Providers
For credit that may be acceptable to state medical associations, specialty societies or state boards for medical licensure, please contact those organizations directly.
Claiming CME Credit
CME credits can be claimed through the online CME system at www.cns.org. The CME system lets you create and print a CME certificate immediately following the CNS Annual Meeting either while you are still in New Orleans or from the convenience of your home or office. You will need to enter the number of hours you are claiming for each session you attended. Physicians should only claim credit for the learning activities at the Annual Meeting in which they actively participated. Upon completion of this process your CME certificate will be sent to you via email at the email address you used at registration.
The Accreditation Council for Continuing Medical Education Standards for Commercial Support requires that anyone in a position to control the content of the educational activity has disclosed all financial relationships with any commercial interest. Failure or refusal to disclose or the inability to satisfactorily resolve the identified conflict may result in the withdrawal of the invitation to participate in any of the CNS educational activities. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling or distributing healthcare goods or services consumed by, or used on, patients. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic. Handout materials are prepared and submitted for distribution by the presenters who are solely responsible for their content.
Some drugs or medical devices demonstrated at the Annual Meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. The CNS policy provides that “off label” uses of a drug or medical device may be described at the Annual Meeting so long as the “off label” use of the drug or medical device is also specifically disclosed. Any drug or medical device is “off label” if the described use is not set forth on the products approval label. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic.